Industry Insights

• 
  The Curtain Has Risen on the Competition for the First Generic Drug, so What Other Innovative Drugs in the Rare Disease Field Can We Look Forward to? Xiaobin
  January 23, 2025
  The CDE website shows Qilu Pharmaceutical applied for the marketing of nusinersen generic. Once controversial for high price, it treats SMA. Now many firms are involved, and SMA treatment progresses.
• 
  Outlook for the Development of Weight-loss Drugs in 2025 Krebs Qin
  January 23, 2025
  This article focuses on the challenges and opportunities for weight-loss drug development in 2025 after semaglutide and tirzepatide's market dominance. It covers GLP-1 drugs' potential in organ protection, new drug mechanisms, and pipeline products.
• 
  Which ADCs Are Favored by Global Companies in 2024? 2 Bispecific ADCs, 5 Transactions Exceeding USD 1 Billion Yi
  January 23, 2025
  ADCs are a hot drug R&D area, with 16 global approvals and a >$10B 2023 market. Chinese firms shine, 2 products approved, 11 out-licensing deals in 2024, 5 over $1B, boosting ADC internationalization.

• 
  How to Implement Proactive Supplier Management in the Pharma Industry Muhammad Asim Niazi
  February 18, 2025
  Proactive supplier management in pharma involves risk assessment, mitigation plans, digital tech use, etc., but faces challenges like budget and communication issues.

• 
  Microbiome Impact on Drug Response and Personalized Medicine Nurah Ekhlaque
  February 18, 2025
• 
  InnoCare Announces the Approval of Registrational Phase III Study of BCL2 Inhibitor ICP-248 in Combination with Orelabrutinib as First-Line Therapy for Treatment of CLL/SLL Patients in China PharmaSources
  February 18, 2025
• 
  Regenerative Medicine and Drug Development: The Intersection of Stem Cells and Biotech Nurah Ekhlaque
  January 17, 2025
  Explore how regenerative medicine and biotech are transforming drug development with stem cell therapies, personalised treatments, and innovative solutions.

• 
  Research and Application of Artemisia Argyi Xiaonisha
  August 12, 2024
  Mugwort, also known as fragrant mugwort or Artemisia argyi, is a herbaceous plant belonging to the Compositae family.
• 
  Research Progress on the Application of Biologics in Pediatric Asthma Xiaomichong
  July 19, 2024
• 
  Research Progress on the Pharmacological Effects and New Drug Forms of Artemisinin and Its Derivatives Xiaomichong
  July 19, 2024

• 
  20 Years of Growth and Innovation in China, Fette Compacting Launches F30p Tablet Press PharmaSources
  December 13, 2024
  Interview Dr. Andreas Risch——Managing Director of Fette Compacting (China) Co., Ltd.